The Rights Offering Reconsidered: A Capital Formation Tool Public Companies Overlook

By Chatsworth Securities | Insights

When a public company needs equity capital, the reflex is to reach for the familiar instruments: a marketed follow-on, a registered direct, an at-the-market program, or a private placement to institutional buyers. The rights offering, in which a company distributes to its existing shareholders the right to purchase additional shares at a set price, often does not make the shortlist. In the United States it is treated as a niche structure, used mainly by closed-end funds and companies in distress. That reputation is partly deserved and largely outdated. For the right issuer in the right situation, a rights offering solves problems the conventional instruments cannot, and dismissing it by default leaves capital and fairness on the table.

This piece sets out how a rights offering actually works, where it has a genuine structural advantage, where its reputation as a distress signal comes from, and what a board should weigh before choosing it. The goal is not to argue that rights offerings are always better. It is to correct an asymmetry in how they are considered, because a board that never evaluates the instrument cannot know when it is the right one.

How the instrument works

In a rights offering, the company grants each existing shareholder a number of rights proportional to their current holding. Each right allows the holder to buy a specified number of new shares at the subscription price, which is typically set at a discount to the prevailing market price to encourage participation. Shareholders who exercise maintain their proportional ownership. Shareholders who decline are diluted, but in many structures they can sell their rights to others, which compensates them for part of the dilution.

Two design choices shape the character of the offering. The first is whether the rights are transferable. Transferable rights can trade, often on the same exchange as the underlying stock, which gives non-participating holders a way to recover value and widens the pool of potential buyers. Non-transferable rights are simpler but offer the holder only a binary choice between exercising and being diluted. The second is whether the offering is backstopped. In a backstopped deal, a standby purchaser, frequently a large existing shareholder, a sponsor, or an underwriter, commits to buy any shares not taken up by the rights holders. A backstop converts an uncertain raise into a committed one, at the cost of fees and, sometimes, the optics of a controlling holder increasing its stake.

The mechanics are not complicated. What makes rights offerings interesting is the set of incentives they create, which differs in kind from a conventional placement.

The structural advantage: fairness as a feature

The defining property of a rights offering is that it extends the opportunity to participate to every existing shareholder on equal terms. In a marketed follow-on or an institutional private placement, the company and its bankers decide who gets to buy the new shares, and the allocation almost always favors large institutions over retail and smaller holders. Existing shareholders who are not invited are diluted without recourse. A rights offering inverts that. The people who already own the company get the first opportunity to maintain their stake, and a discounted one at that.

This matters for two distinct reasons. The first is governance. Boards have a duty to treat shareholders fairly, and pre-emptive rights, the right of existing holders to avoid dilution, are a longstanding principle of shareholder protection. In much of Europe, pre-emptive rights are effectively mandatory for equity issuances above a threshold, which is why rights offerings are a mainstream instrument there rather than an exotic one. A board that issues equity through a structure that protects its existing owners from forced dilution is on firmer ground than one that dilutes them to favor new institutional entrants.

The second reason is practical alignment. Because the buyers are existing shareholders, the new capital comes from parties who already understand the business and have chosen to be in it. That tends to produce a more stable post-issuance shareholder base than a placement to event-driven institutions who may exit once a lockup or catalyst passes. For a company whose register it wishes to keep stable, the composition of the buyer pool is not a detail. It is part of the point.

Where the distress reputation comes from

The instrument's poor reputation in the United States is not arbitrary. It reflects a real pattern of adverse selection. Companies that can readily access institutional capital usually do, because a marketed follow-on is faster, requires less shareholder coordination, and does not signal that the company was unable to place stock with new investors. The issuers left reaching for rights offerings have historically skewed toward those that institutions would not fund on attractive terms: companies in turnaround, in sectors out of favor, or with balance sheets that needed repair more than growth capital. When the market sees a rights offering, it often infers that the conventional doors were closed.

A deep discount can compound the signal. Distressed issuers frequently price rights offerings at steep discounts to ensure the raise completes, and a steep discount can read as a company that had to pay heavily for capital. The market reaction to the announcement then reflects the inference about why the structure was chosen, not the structure itself.

The honest conclusion is that the distress association is a correlation, not a property of the instrument. A rights offering does not make a company distressed any more than a follow-on makes it healthy. But a board considering one has to account for how the market reads the choice, and the burden of overcoming that inference falls on the issuer. That burden is real, and it is the single biggest reason a fundamentally sound company might still avoid the structure. It is also surmountable through clear communication of the rationale, a sensible discount rather than a punitive one, and, where appropriate, a credible backstop that signals insider conviction.

What a board should weigh

The decision to use a rights offering turns on a handful of questions, and they are worth asking explicitly rather than letting the default carry the day.

The first is the shareholder base. A rights offering works best when the existing register is engaged and has the capacity and appetite to participate. A retail-heavy base with low participation rates may leave much of the offering unsubscribed, which is when a backstop becomes important. A base anchored by a sophisticated long-term holder willing to backstop the deal turns the structure from a gamble into a controlled raise.

The second is the signaling environment. A company with a clear, well-understood growth use of proceeds can frame a rights offering as an invitation to existing owners to fund the next phase on favorable terms. A company in a fragile position will find the market less willing to extend that benefit of the doubt. The same instrument tells a different story depending on who issues it and why, and the board should be honest about which story applies to it.

The third is the alternative cost of dilution and control. A backstopped rights offering in which a single large holder takes up the unsubscribed shares can shift control, which may be acceptable or may be exactly what minority holders should worry about. The board's fairness duty cuts both ways here. The structure protects participating shareholders from dilution, but a backstop concentrated in one party can advantage that party at the expense of those who do not or cannot participate. Independent scrutiny of backstop terms is warranted.

The fourth is execution complexity and timing. A rights offering requires a subscription period, shareholder communication, and, for transferable rights, a trading market for the rights themselves. It is slower than an overnight follow-on. For a company that needs capital immediately, that timeline can be disqualifying. For one that can plan, the additional time buys fairness and a more durable shareholder base.

The reconsideration

The case for taking rights offerings seriously is not that they are universally superior. It is that they occupy a position no other instrument does. They are the only common equity structure that extends the opportunity to participate to every existing owner on equal terms, and that property has real value in governance, in shareholder alignment, and in the durability of the resulting register. The instrument's distress reputation is a market inference that a sound issuer can manage, not a defect in the structure.

The practical failure is not that companies choose follow-ons over rights offerings. Often that is the correct choice. The failure is that many boards never evaluate the rights offering at all, treating it as a structure for distressed companies and closed-end funds rather than as one option among several. A board that understands when the instrument's fairness and alignment properties outweigh its signaling burden and its timeline will occasionally find that the overlooked tool is the right one. That judgment is only available to the board that bothers to consider it.

Chatsworth Securities is a FINRA-registered broker-dealer advising on capital formation, mergers and acquisitions, and corporate development for public and private companies. This article is for general informational purposes and is not an offer to sell or a solicitation to buy any security, nor investment advice regarding any specific transaction.